Why is Rainbow Child. falling/rising?

As of 04-Nov, Rainbow Childrens Medicare Ltd is experiencing a price increase, currently at 1,390.70, reflecting a rise of 15.8 or 1.15%. The stock has been gaining for the last two days, with a total return of 1.58% during this period, and it has outperformed its sector by 1.5%. However, despite these short-term gains, the stock has underperformed over the longer term, with a year-to-date decline of 7.17% and a one-year drop of 14.72%. The company boasts high management efficiency with a return on capital employed (ROCE) of 20.02% and a low debt to EBITDA ratio of 0.86, indicating strong financial health. Nonetheless, the stock's valuation appears expensive, and it has shown poor long-term growth, with operating profit growth of only 17.48% over the last five years.
In the broader market context, the stock's recent performance contrasts with the benchmark, as it has gained 1.04% over the past week while the Sensex has declined by 1.38%. Despite this short-term outperformance, the stock has significantly lagged behind the market over the past year, where the benchmark has returned 4.72% compared to the stock's negative return of 14.72%. This underperformance highlights the challenges the company faces, including flat quarterly results and a high PEG ratio of 2.8, suggesting that while the stock may be temporarily rising, its long-term prospects remain uncertain amidst broader market trends.